Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05807061 · ClinicalTrials.gov registry record · NA

Reducing Children's Racial Biases Via a Parent-Led Intervention

A NA study, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
704
Enrollment target

NCT05807061: Completed NA study, sponsored by University of Wisconsin, Madison.

NCT05807061 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 704 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (50% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05807061, a NA study, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
704 participants
Enrollment target

Study Summary

The goal of this clinical trial is to test a parent-led program for reducing children's racial biases in White families. The main question it aims to answer is: With training, can parents effectively address their children's racial biases? Parent will receive training and tools for addressing their children's racial biases. Researchers will study effects on both parents' and children's racial biases.

Primary Outcome

Total possible range of scores from 1-5. Higher scores mean higher likelihood of bias.

Interventions

  • BEHAVIORAL EmBARK
  • BEHAVIORAL Popular guidance
  • BEHAVIORAL Practice first

Trial Details

FieldValue
Enrollment Target 704 participants
Start Date 2023-04-25
Est. Completion 2026-01-15
Phase NA
University of Wisconsin, Madison

1,039 total trials

What the finished NCT05807061 record still lists

NCT05807061 is an interventional study that assigns participants to a tested intervention. The registered 704 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (50% lower).

The record links to 0 conditions, and to 3 interventions - of which EmBARK is the first listed.

NCT05807061 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05807061 about?

NCT05807061 is a clinical study titled "Reducing Children's Racial Biases Via a Parent-Led Intervention". The goal of this clinical trial is to test a parent-led program for reducing children's racial biases in White families. The main question it aims to answer is: With training, can parents effectively address their children's racial biases? Parent will receive training and tools for addressing their ...

What is the current status of trial NCT05807061?

This trial is currently completed. It is a NA study. The enrollment target is 704 participants. The study started on 2023-04-25. Estimated completion is 2026-01-15.

What interventions are being tested in trial NCT05807061?

The interventions under investigation include: EmBARK (BEHAVIORAL), Popular guidance (BEHAVIORAL), Practice first (BEHAVIORAL).

Who is sponsoring clinical trial NCT05807061?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05807061's enrollment target sits among peer trials

704 148th of 2000 higher than 1,853 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05796687 · 704 participants · NA

    Evaluation of My Future Self, an New Teen Pregnancy Prevention Group Intervention for Youth in Non-traditional Settings

  • NCT06350734 · 704 participants

    Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study

  • NCT06480383 · 705 participants · Phase 2

    Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder

  • NCT07067463 · 705 participants · Phase 3

    A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05807061, the US trial registry maintained by the National Library of Medicine. NCT05807061 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.